By Josh White
Date: Thursday 18 Dec 2025
(Sharecast News) - PureTech Health announced the appointment of Robert Lyne as chief executive officer and a member of its board with immediate effect on Thursday.
By Iain Gilbert
Date: Thursday 28 Aug 2025
(Sharecast News) - Biotherapeutics firm Puretech Health said on Thursday that it had made "meaningful progress" across its portfolio in the first half of 2025, with contract revenues soaring throughout the period.
By Josh White
Date: Tuesday 12 Aug 2025
(Sharecast News) - PureTech Health announced the launch of Celea Therapeutics on Tuesday, a new company focused on developing treatments for serious respiratory diseases, led by former Teva North America chief executive Sven Dethlefs.
| Currency | UK Pounds |
| Share Price | 131.80p |
| Change Today | -3.00p |
| % Change | -2.23 % |
| 52 Week High | 146.60 |
| 52 Week Low | 106.40 |
| Volume | 666,375 |
| Shares Issued | 243.42m |
| Market Cap | £320.83m |
| Beta | 0.01 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
| Time | Volume / Share Price |
| 16:35 | 108,293 @ 131.80p |
| 16:35 | 179 @ 131.80p |
| 16:35 | 447 @ 131.80p |
| 16:35 | 108 @ 131.80p |
| 16:35 | 101 @ 131.80p |
You are here: research